Publicaciones en las que colabora con Alberto Gutiérrez Calvo (23)

2024

  1. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

2022

  1. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

  2. Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study (PANMEKID)

    European Journal of Surgical Oncology, Vol. 48, Núm. 1, pp. 133-141

2021

  1. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

    The Lancet Oncology, Vol. 22, Núm. 11, pp. 1507-1517

  2. The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Delaying surgery for patients with a previous SARS-CoV-2 infection

    British Journal of Surgery

  2. Patterns of acute surgical inflammatory processes presentation of in the COVID-19 outbreak (PIACO Study): Surgery may be the best treatment option

    British Journal of Surgery

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236

2014

  1. Estudio multicéntrico sobre adenomas hepáticos

    Cirugia Espanola, Vol. 92, Núm. 2, pp. 120-125

2006

  1. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 55, Núm. 6, pp. 744-748

2003

  1. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 52, Núm. 11, pp. 708-714

2000

  1. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy

    Anticancer Research, Vol. 20, Núm. 5 C, pp. 3929-3933

1996

  1. A comparative study on the prognostic value of the nuclear expression of protein p53 vis-à-vis histopathology in colorectal cancer

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 13, Núm. 5, pp. 222-226

  2. Acute Small Bowel Obstruction Caused by Endometriosis

    European Journal of Surgery, Vol. 162, Núm. 9, pp. 747-749

1995

  1. Prediction of recurrence in B-C stages of colorectal cancer by p53 nuclear overexpression in comparison with standard pathological features

    European Journal of Surgical Oncology, Vol. 21, Núm. 6, pp. 635-639

  2. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer

    International Journal of Biological Markers, Vol. 10, Núm. 1, pp. 5-10

1989

  1. Diverticulitis del colon perforada: diagnóstico y tratamiento.

    Revista Espanola de las Enfermedades del Aparato Digestivo, Vol. 75, Núm. 1, pp. 21-24

  2. Doble fístula biliar interna-externa espontánea simultánea.

    Revista Espanola de las Enfermedades del Aparato Digestivo, Vol. 75, Núm. 2, pp. 198-200

1988

  1. Cistoadenoma mucinoso de páncreas.

    Revista quirurgica espanola : RQE, Vol. 15, Núm. 4, pp. 203-205

  2. Linfomas gástricos primarios.

    Revista quirurgica espanola : RQE, Vol. 15, Núm. 5, pp. 219-222